Mutant p53 Protein as a Predictor of Survival in Endometrial Carcinoma

By Strang P.   Nordstrom B.   Nilsson S.   Bergstrom R.   Tribukait B.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 598-602

Elsevier

Access to resources Recommend Favorite

Reactivation of mutant p53: a new strategy for cancer therapy

By Selivanova G.   Kawasaki T.   Ryabchenko L.G.   Wiman K.G.  

Seminars in Cancer Biology, Vol. 8, Iss. 5, 1997-10 ,pp. : 369-378

Academic Press

Access to resources Recommend Favorite

p53 Interference and Growth Inhibition in p53-Mutant and Overexpressing Endometrial Cancer Cell Lines

By Janicek M.F.   Angioli R.   Unal A.D.   Sevin B.-U.   Madrigal M.   Estape R.   Averette H.E.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 94-102

Elsevier

Access to resources Recommend Favorite

Induction of apoptosis by cytoplasmically localized wild-type p53 and the S121F mutant super p53

By                

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 978-982

Spandidos Publications

Access to resources Recommend Favorite

Restoration by glycerol of p53-dependent apoptosis in cells bearing the mutant p53 gene

By Ohnishi T.   Matsumoto H.   Wang X.   Takahashi A.   Tamamoto T.   Ohnishi K.  

International Journal of Radiation Biology, Vol. 75, Iss. 9, 1999-09 ,pp. : 1095-1098

Informa Healthcare

Access to resources Recommend Favorite